Found 40 matching trials
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma PHASE2 The purpose of this study is to determine the safety and tolerability of Re...
Show More Location
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Learn More & Join Trial
Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer PHASE2 The purpose of this study is to assess the efficacy and safety of single-ag...
Show More Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Learn More & Join Trial
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer PHASE2 The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Show More Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Learn More & Join Trial
Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab PHASE2 The purpose of this study is to assess the efficacy of single-agent regoraf...
Show More Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Learn More & Join Trial
Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors PHASE1 Advanced solid tumors remain a major therapeutic challenge due to their com...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients PHASE1 This study will evaluate the addition of regorafenib to standard of care tr...
Show More Location
Istituto Oncologico Veneto IRCCS
Learn More & Join Trial
Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer N/A The purpose of this trial is to quantitatively assess the average amount of...
Show More Location
Klinikum Kreuzschwestern Wels GmbH
Learn More & Join Trial
Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer PHASE2 A randomized, phase II study comparing the sequences of regorafenib and tri...
Show More Location
Clinique Saint Luc
Learn More & Join Trial
A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes? PHASE4 Randomized trial to evaluate impact of healthcare provider( clinician and n...
Show More Location
Multiple Locations
Learn More & Join Trial